ACTUAL QUESTIONS AND CORRECT ANSWERS (VERIFIED
ANSWERS) PLUS RATIONALES Q&A INSTANT DOWNLOAD PDF.
48 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Differentiate psychotropic agents by receptor binding profiles, pharmacokinetics, and clinical indications
2 Analyze drug-drug and drug-gene interactions to optimize therapeutic efficacy and minimize adverse
effects
3 Apply current FDA safety warnings, monitoring parameters, and evidence-based guidelines to complex
psychiatric scenarios
4 WILKES NSG 552 EXAM 2 PSYCHOPHARMACOLOGY
5 2026
6 ACTUAL QUESTIONS AND CORRECT ANSWERS
7 VERIFIED ANSWERS
8 PLUS RATIONALES Q&A INSTANT DOWNLOAD PDF.
9 Foundations of Psychopharmacology
10 Applied Psychopharmacology
11 Advanced Psychopharmacology
12 Psychopharmacology Review
ABSTRACT
Page 1
,This study document brings together 48 carefully worded exam questions drawn from WILKES
NSG 552 EXAM 2 PSYCHOPHARMACOLOGY (2026) ACTUAL QUESTIONS AND CORRECT
ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES Q&A INSTANT DOWNLOAD PDF., with
the strongest emphasis placed on Differentiate psychotropic agents by receptor binding profiles,
pharmacokinetics, and clinical indications, Analyze drug-drug and drug-gene interactions to
optimize therapeutic efficacy and minimize adverse effects, Apply current FDA safety warnings,
monitoring parameters and and evidence-based guidelines to complex psychiatric scenarios. Every
item follows the wording style and level of reasoning you meet in the real paper, and each one is
paired with a clear rationale so the correct choice is never a guess. Work through the set at your
own pace, mark the questions that slow you down, then come back to them until the reasoning
feels automatic. Learners who revise this way walk into the exam room recognising the pattern
behind the questions instead of meeting them for the first time. Keep going - steady, honest
practice is what turns a difficult paper into a comfortable pass.
Q1 DIFFERENTIATE PSYCHOTROPIC AGENTS BY RECEPTOR BINDING PROFILES,
PHARMACOKINETICS, AND CLINICAL INDICATIONS
A patient with treatment-resistant depression is prescribed phenelzine. Which
dietary component most specifically necessitates strict avoidance due to a
dose-dependent hypertensive crisis risk?
A. Tyramine CORRECT
B. Tryptophan
C. Caffeine
D. Histamine
RATIONALE: Tyramine, found in aged cheeses and cured meats, is normally metabolized by
MAO-A; phenelzine irreversibly inhibits MAO-A, allowing tyramine to trigger massive
norepinephrine release and hypertensive crisis. Tryptophan and caffeine do not cause this
specific reaction, and histamine is not the primary dietary amine implicated.
Page 2
, Q2 DIFFERENTIATE PSYCHOTROPIC AGENTS BY RECEPTOR BINDING PROFILES,
PHARMACOKINETICS, AND CLINICAL INDICATIONS
Which laboratory parameter is most critical to monitor in a patient initiated on
clozapine, given its potential to cause a rare but life-threatening adverse effect?
A. Absolute neutrophil count CORRECT
B. Serum creatinine
C. Liver function tests
D. Fasting lipid panel
RATIONALE: Clozapine carries a boxed warning for severe neutropenia/agranulocytosis,
requiring regular ANC monitoring per REMS. While clozapine can affect liver enzymes and lipids,
the most critical and uniquely mandated monitoring is ANC. Renal function is not the primary
concern.
Q3 DIFFERENTIATE PSYCHOTROPIC AGENTS BY RECEPTOR BINDING PROFILES,
PHARMACOKINETICS, AND CLINICAL INDICATIONS
A patient on lithium therapy presents with coarse hand tremor, ataxia, and
confusion. Which condition most likely explains these findings?
A. Lithium toxicity CORRECT
B. Serotonin syndrome
C. Neuroleptic malignant syndrome
D. Acute dystonia
RATIONALE: Coarse tremor, ataxia, and confusion are classic signs of lithium toxicity, often
precipitated by dehydration or drug interactions. Serotonin syndrome presents with clonus and
hyperreflexia; NMS includes rigidity and fever; acute dystonia involves sustained muscle
contractions.
Page 3